Location History:
- Kanagawa, JP (2014)
- Fujisawa, JP (2017)
- Fujisawa Kanagawa, JP (2023)
Company Filing History:
Years Active: 2014-2024
Title: Shumpei Murata: Innovator in Cyclic Dinucleotide Research
Introduction
Shumpei Murata is a prominent inventor based in Fujisawa, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target STING-related diseases. With a total of 4 patents to his name, Murata's work is paving the way for innovative therapeutic solutions.
Latest Patents
Murata's latest patents include groundbreaking methods for making cyclic dinucleotides. One of his notable inventions is a compound that exhibits STING agonistic activity, which holds promise for the prophylaxis or treatment of STING-related diseases. This patent details a compound represented by a specific formula, where each symbol is defined in the accompanying description. Another significant patent involves antibody-drug conjugates that also leverage the STING agonistic activity, further emphasizing the potential of these compounds in therapeutic applications.
Career Highlights
Shumpei Murata is currently associated with Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. His role at Takeda allows him to collaborate with other experts in the field and contribute to the advancement of innovative medical solutions.
Collaborations
Murata has worked alongside notable colleagues such as Tadashi Umemoto and Masato Yoshikawa. Their collaborative efforts have been instrumental in driving forward the research and development of new therapeutic agents.
Conclusion
Shumpei Murata's contributions to the field of cyclic dinucleotide research highlight his role as an influential inventor. His innovative patents and collaborations are set to make a significant impact on the treatment of STING-related diseases.